EU Court Criticizes European Commission for Lack of Transparency in COVID-19 Vaccine Deal Details

The European Commission was criticized for not providing sufficient public access to information regarding COVID-19 vaccine purchase agreements with pharmaceutical companies during the pandemic. This decision was made just a day before a vote at the European Parliament, where President Ursula von der Leyen is seeking re-election. The EU General Court ruled that the Commission did not provide enough transparency on its vaccine contracts, prompting criticism from lawmakers who had taken legal action to gain access to this information.